Substance / Medication

Ciprofloxacin hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

38 trials linked to this intervention

38
Total Trials
9
Recruiting
6
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Yield and clinical impact of image-guided bone biopsy in osteomyelitis of the appendicular skeleton: a systematic review and meta-analysis.
Smayra Karen, Miangul Shahid, Witkowiak Maria M et al. · Skeletal Radiol · 2025
PMID: 39080029Meta-AnalysisFull text (PMC)
Does vesicoureteric reflux diagnosed following prenatal urinary tract dilatation need active management? A narrative review.
Farrugia Marie-Klaire, Montini Giovanni · J Pediatr Urol · 2025
PMID: 39406669Meta-Analysis
Hand Osteomyelitis: A Systematic Review of the Literature and Recommendations for Diagnosis and Management.
Dargan Dallan, Wyman Matthew, Bhoora Mahir et al. · Hand (N Y) · 2025
PMID: 39462293Meta-AnalysisFull text (PMC)
Ultrasound for acute pyelonephritis: a systematic review and meta-analysis.
Yu Jessica, Sri-Ganeshan Muhuntha, Smit De Villiers et al. · Intern Med J · 2024
PMID: 38339768Meta-Analysis
PIC cystography in occult vesicoureteral reflux: A systematic review highlighting its utility in children with recurrent urinary tract infections and normal VCUG.
Pakkasjärvi Niklas, Ripatti Liisi, Läckgren Göran et al. · J Pediatr Urol · 2023
PMID: 37633825Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ciprofloxacin hydrochloride (substance)
SNOMED CT
20450009
UMLS CUI
C0282104

Clinical Data

This intervention maps to 25 entities in the Ltrl knowledge graph.

20
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
38
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Ciprofloxacin hydrochloride: Uses, Evidence & Side Effects | Ltrl